These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10467950)

  • 1. Preparation, relative toxicity and therapeutic efficacy in mice and rats of liposomal HA-1-92, a new oxohexaene polyene macrolide antibiotic.
    Harindran J; Chakraborty KK; Naik SR
    J Pharm Pharmacol; 1999 Jul; 51(7):771-6. PubMed ID: 10467950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic activity of liposomal SJA-95: a new polyene macrolide antibiotic in experimental aspergillosis and cryptococcosis.
    Desai SK; Naik SR
    Biomed Pharmacother; 2009 May; 63(4):287-92. PubMed ID: 18848764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
    Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of immunological aspects of aspergillosis in mice and effect of polyene macrolide antibiotic (SJA-95) and IFN-γ: a possible role of IFN-γ as an adjunct in antifungal therapy.
    Naik SR; Thakare VN; Desai SK; Rahalkar PR
    Immunol Lett; 2011 Dec; 141(1):68-73. PubMed ID: 21839115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental systemic mycoses with BRL 49594A.
    Najvar LK; Luther MF; Graybill JR
    J Antimicrob Chemother; 1995 Dec; 36(6):1005-1011. PubMed ID: 8821599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of an experimental murine model of invasive pulmonary aspergillosis.
    Sheppard DC; Graybill JR; Najvar LK; Chiang LY; Doedt T; Kirkpatrick WR; Bocanegra R; Vallor AC; Patterson TF; Filler SG
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3501-3. PubMed ID: 17005844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics.
    Groll AH; Gonzalez CE; Giri N; Kligys K; Love W; Peter J; Feuerstein E; Bacher J; Piscitelli SC; Walsh TJ
    J Antimicrob Chemother; 1999 Jan; 43(1):95-103. PubMed ID: 10381106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic, hypoprostatic and pharmacological activity of oxohexaene polyene antibiotic (HA-1-92).
    Naik SR; Harindran J
    Indian J Exp Biol; 2000 Jul; 38(7):727-9. PubMed ID: 11215318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
    Chiang LY; Ejzykowicz DE; Tian ZQ; Katz L; Filler SG
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin-B in the control of experimental aspergillosis in mice: Part I--Relative therapeutic efficacy of free and liposomal amphotericin-B.
    Ahmad I; Sarkar AK; Bachhawat BK
    Indian J Biochem Biophys; 1989 Dec; 26(6):351-6. PubMed ID: 2698855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
    Troke PF; Andrews RJ; Marriott MS; Richardson K
    J Antimicrob Chemother; 1987 May; 19(5):663-70. PubMed ID: 3038824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal hamycin in the control of experimental aspergillosis in mice: relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin.
    Moonis M; Ahmad I; Bachhawat BK
    Indian J Biochem Biophys; 1992 Aug; 29(4):339-45. PubMed ID: 1427960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
    Sionov E; Mendlovic S; Segal E
    J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice.
    Ahmad I; Sarkar AK; Bachhawat BK
    Indian J Biochem Biophys; 1990 Dec; 27(6):370-4. PubMed ID: 2102483
    [No Abstract]   [Full Text] [Related]  

  • 15. Liposomal hamycin in the control of experimental aspergillosis in mice: effect of phosphatidic acid with and without cholesterol.
    Moonis M; Ahmad I; Bachhawat BK
    J Antimicrob Chemother; 1993 Apr; 31(4):569-79. PubMed ID: 8514651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.
    Falk R; Grunwald J; Hoffman A; Domb AJ; Polacheck I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3606-9. PubMed ID: 15328139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing Role of Macrolide Anti-inflammatory Therapy in Secondary Organizing Pneumonia.
    Flora AS; Simo H; Assaly R
    Am J Ther; 2017; 24(4):e495. PubMed ID: 28166162
    [No Abstract]   [Full Text] [Related]  

  • 18. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
    van de Sande WW; van Vianen W; ten Kate MT; Vissers J; Laurijsens J; Tavakol M; Rijnders BJ; Mathot RA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
    Khan MA; Aljarbou A; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):88-97. PubMed ID: 22612788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
    J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.